Akoya Biosciences Inc (AKYA)
2.12
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
2.12
0.00 (0.00%)
After-Hours: 18:13
Akoya Biosciences Total Assets (Quarterly): 129.97M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 129.97M |
| June 30, 2024 | 143.74M |
| March 31, 2024 | 154.75M |
| December 31, 2023 | 180.37M |
| September 30, 2023 | 177.24M |
| June 30, 2023 | 188.88M |
| March 31, 2023 | 154.30M |
| December 31, 2022 | 176.03M |
| Date | Value |
|---|---|
| September 30, 2022 | 176.46M |
| June 30, 2022 | 184.26M |
| March 31, 2022 | 187.13M |
| December 31, 2021 | 190.91M |
| September 30, 2021 | 195.41M |
| June 30, 2021 | 206.34M |
| March 31, 2021 | 74.48M |
| December 31, 2020 | 77.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
74.48M
Minimum
Mar 2021
206.34M
Maximum
Jun 2021
162.37M
Average
176.85M
Median
Total Assets (Quarterly) Benchmarks
| Bruker Corp | 6.113B |
| Azenta Inc | 2.100B |
| Harvard Bioscience Inc | 131.24M |
| Bionano Genomics Inc | 87.36M |
| Singular Genomics Systems Inc | 186.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 116.34M |
| Shareholders Equity (Quarterly) | 13.63M |
| Debt to Equity Ratio | 5.568 |
| Current Ratio | 2.746 |
| Net Debt Paydown Yield | -1.82% |